XML 44 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Note 10 - Net Loss Per Share
3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Earnings Per Share [Text Block]
Note 
10
 — Net Loss Per Share
 
The following table (in thousands, except for loss per share) reconciles basic and diluted weighted average common shares outstanding for each of the
three
months ended
March 31, 2020
and
2019
:
 
   
Three Months Ended
 
   
March 31,
 
   
2020
   
2019
 
Weighted average common shares outstanding:
               
Basic
   
117,353
     
106,940
 
Dilutive unvested stock, convertible preferred stock, Common Stock Warrants and IPO Warrants
   
     
 
Diluted
   
117,353
     
106,940
 
                 
Basic and diluted net loss per share attributable to common stockholders
  $
(0.02
)   $
(0.16
)
 
Potentially dilutive securities
not
included in the diluted net loss per share computations because their effect would have been anti-dilutive were as follows (in thousands):
 
   
Three Months Ended
 
   
March 31,
 
   
2020
   
2019
 
Unvested stock
(1)
   
1,160
     
490
 
Convertible preferred stock
   
15,905
     
11,127
 
Common Stock Warrants
   
1,964
     
1,376
 
IPO Warrants
(2)
   
12,082
     
12,082
 
Total potentially dilutive common shares
   
31,111
     
25,075
 
 

(
1
)
Does
not
include
2.8
million shares and
10.8
million shares for the
three
months ended
March 31, 2020
and
2019
, respectively, of unvested stock because the performance conditions had
not
yet been satisfied.
 
(
2
)
The IPO Warrants were issued in connection with our initial public offering in
2015.
The IPO Warrants are exercisable at a price of
$11.50
per share and expire on
July 24, 2022.
The Company
may
redeem the IPO Warrants at a price of
$0.01
per IPO Warrant upon
30
days’ notice only if the last sale price of our common stock is at least
$17.50
per share for any
20
trading days within a
30
-trading day period. If the Company redeems the IPO Warrants in this manner, the Company will have the option to do so on a cashless basis with the issuance of an economically equivalent number of shares of Company common stock.